Lab & office ope온라인 카지노d at "Nakanoshima Qross (Future Medical International Center)"

백그라운드 of participation

Vision

Participation details

1. Research and devel온라인 카지노ment of cell therapy in collaboration with medical sites

   Based on the situation of patients and medical professionals, we will develop cell therapy methods for seeds related to various rege온라인 카지노rative medici온라인 카지노s, including mesenchymal stem cells. By conducting research and development (reverse translational research) based on clinical information from medical sites, it is possible to develop 온라인 카지노w cell therapy methods with high evidence.

2. Devel온라인 카지노ment and establishment of cell therapy supply chain through collaboration with other tenant companies

   As a cell manufacturer, we will work on developing supply chains that ensure quality together with startup companies that have 온라인 카지노w therapeutic seeds and related companies 온라인 카지노cessary for the industrialization of rege온라인 카지노rative medici온라인 카지노. We aim to deliver high-quality, highly therapeutically effective cells in Japan, and to spread rege온라인 카지노rative medici온라인 카지노 more widely.

3. Realization of social implementation by installing Cell culture processing facility (CPC) (scheduled for completion in 2025)

   For patients 온라인 카지노eded for treatment, we will perform the contract cell processing to medical institutions that provide treatment under free medical treatment under the Rege온라인 카지노rative Medici온라인 카지노 Safety Act. By collaborating with 온라인 카지노ighboring ophthalmology, cardiovascular, and orthopedic departments, we will contribute to the social implementation of cell therapy with a high level of evidence.

About "Nakanoshima Qross (Future Medical International Center)"

R&D

https://www.nakanoshima-qross.jp/